<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201207194203N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-08-16</date_registration>
      <primary_sponsor>Deputy of Research, Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Hamstring muscle stretching and Whole body vibration</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of the effect of  whole body vibration and subjects' position on hamstring flexibility in subjects with hamstring shortness.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/4430</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Muscle contracture.</hc_freetext>
      <i_freetext>Intervention 1: Control (1): Stretching of both hamstrings simultaneously, without WBV. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks. Intervention 2: Intervention (1): Stretching of both hamstrings simultaneously, on WBV platform when it is on. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval. The parameters of WBV are as follows: High amplitude and frequency of 30 Htz.  Stretches will be done 3 times per week for 4 weeks. Intervention 3: Intervention (2): Stretching of hamstrings individually on WBV platform when it is on. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval, separately. The parameters of WBV are as follows: High amplitude and frequency of 30 Htz. Stretches will be done 3 times per week for 4 weeks. Intervention 4: Intervention (3): The subject firstly will receive WBV for 5 sets of 30 seconds with 20 s rest interval in squat position.  After receiving WBV, stretch will be perform for both hamstrings simultaneously, for 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks. Intervention 5: Intervention (4): The subject firstly will receive WBV for 5 sets of 30 seconds with 20 s rest interval in squat position.  After receiving WBV, stretch will be perform for individual hamstrings separately, for 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks. Intervention 6: Control (2): Stretching of hamstrings individually without WBV. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval, separately Stretches will be done 3 times per week for 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Atefeh Aminian Far</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kilometer 5 Damghan road, Semnan University of Medical Sciences</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439957181</zip>
        <telephone>+98 23 1335 4182</telephone>
        <email>aminfar@sem-ums.ac.iraminfar83@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Atefeh Aminian Far</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kilometer 5 Damghan road, Semnan University of Medical Sciences</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439957181</zip>
        <telephone>+98 23 1335 4182</telephone>
        <email>aminfar@sem-ums.ac.iraminfar83@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:Presence of hamstring shortness confirmed with 90-90 test. &#13;
 Female students&#13;
Exclusion criteria: Orthopedic and neurological disorders, previous history of lower limb surgery, lower limb fracture, hamstring strain during last year, disease like arthritis, ligament and meniscus injury, previous history of spinal surgery, spinal trauma, previous history of regular sport activity during last year, previous history of aerobic program during last 6 months, previous history of cardiovascular and respiratory disease.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M62.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Contracture of muscle</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control (1): Stretching of both hamstrings simultaneously, without WBV. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks..</i_keyword>
      <i_keyword>Intervention (1): Stretching of both hamstrings simultaneously, on WBV platform when it is on. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval. The parameters of WBV are as follows: High amplitude and frequency of 30 Htz.  Stretches will be done 3 times per week for 4 weeks.</i_keyword>
      <i_keyword>Intervention (2): Stretching of hamstrings individually on WBV platform when it is on. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval, separately. The parameters of WBV are as follows: High amplitude and frequency of 30 Htz. Stretches will be done 3 times per week for 4 weeks.</i_keyword>
      <i_keyword>Intervention (3): The subject firstly will receive WBV for 5 sets of 30 seconds with 20 s rest interval in squat position.  After receiving WBV, stretch will be perform for both hamstrings simultaneously, for 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks.</i_keyword>
      <i_keyword>Intervention (4): The subject firstly will receive WBV for 5 sets of 30 seconds with 20 s rest interval in squat position.  After receiving WBV, stretch will be perform for individual hamstrings separately, for 5 sets of 30 seconds with 20 s rest interval. Stretches will be done 3 times per week for 4 weeks.</i_keyword>
      <i_keyword>Control (2): Stretching of hamstrings individually without WBV. Stretch will be perform in 5 sets of 30 seconds with 20 s rest interval, separately Stretches will be done 3 times per week for 4 weeks..</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee range of motion limitation. Timepoint: Before Intervention, 4 weeks following the intervention, 1 month following end of intervention. Method of measurement: through goniometry by 90-90 test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Deputy of Research, Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-07-11</approval_date>
        <contact_name>Deputy of Research, Semnan University of Medical Sciences</contact_name>
        <contact_address>Bassij Blvd, Semnan University of Medical Sciences, Deputy of Research, Semnan, Iran. Semnan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
